SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-24-002522
Filing Date
2024-08-09
Accepted
2024-08-09 16:07:29
Documents
40
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk2431762.htm   iXBRL 10-Q 962314
2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES OXLEY ACT OF 2002 exhibit_31-1.htm EX-31.1 12970
3 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES OXLEY ACT OF 2002 exhibit_31-2.htm EX-31.2 13088
4 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002 exhibit_32-1.htm EX-32.1 4947
5 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002 exhibit_32-2.htm EX-32.2 5338
  Complete submission text file 0001178913-24-002522.txt   3923739

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE entx-20240630.xsd EX-101.SCH 54006
7 XBRL CALCULATION FILE entx-20240630_cal.xml EX-101.CAL 26935
8 XBRL DEFINITION FILE entx-20240630_def.xml EX-101.DEF 56962
9 XBRL LABEL FILE entx-20240630_lab.xml EX-101.LAB 789277
10 XBRL PRESENTATION FILE entx-20240630_pre.xml EX-101.PRE 151662
42 EXTRACTED XBRL INSTANCE DOCUMENT zk2431762_htm.xml XML 334134
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38556 | Film No.: 241192771
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)